The Anavex 2-73 Study

Do you or your loved one have Alzheimer’s Disease?

Are you interested in taking part in a clinical trial?

NeuroCentrix invites you to learn more about a clinical research study involving the use of a new investigational medication.

Who can take part?*

  • Aged 60-85
  • A diagnosis of early Alzheimer’s Disease
  • Availability of a study partner who spends at least 10 hours per week with the participant

What to expect

  • Study duration of approximately 48 weeks including 6 on-site visits
  • Study-related care, medical and cognitive assessments and study medication every 3 months

*Please note that there are additional criteria that must be met in order to qualify to participate in this study.

Interested?
Contact NeuroCentrix Research Team
Tell us how to contact you